Integral Corporation (FRA:Q75)

Blueprint Medicines Revenue

Integral had revenue of 1.00B JPY in the quarter ending March 31, 2025, a decrease of -79.99%. This brings the company's revenue in the last twelve months to 27.22B, up 71.32% year-over-year. In the year 2024, Integral had annual revenue of 31.23B with 121.82% growth.

• Revenue (ttm): 27.22B JPY
• Revenue Growth: +71.32%
• P/S Ratio: 4.08
• Revenue / Employee: 331.95M JPY
• Employees: 82
• Market Cap: 686.72M USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.23B	17.15B	121.82%
Dec 31, 2023	14.08B	8.65B	159.24%
Dec 31, 2022	5.43B	1.57B	40.64%
Dec 31, 2021	3.86B	1.85B	92.09%
Dec 31, 2020	2.01B	-529.70M	-20.86%